Features

21st Annual $alary $urvey

The results from our Annual Salary & Job Satisfaction Survey are in!

Tim Wright, Editor, Contract Pharma06.04.20

Welcome to Contract Pharma’s 21^st Annual Salary & Job Satisfaction Survey! This year’s results are derived from more than 200 respondents from our readership about employment attitudes, responsibilities, education, and their 2019 salaries.

Quick Hits

Respondent Gender: 76% male, 24% female
Respondent Sector: 70% pharma/biopharma; 17% contract research; 13% lab services
Avg. 2019 base salary (all respondents): $129,735
Avg. 2019 bonus (all): $21,872
Avg. 2019 stock options (all): $11,631
Avg. 2019 benefits (all): $16,754
Avg. 2019 base salary for men: $139,379
Avg. 2019 base salary for women: $115,456

Charts and graphics by Scott Garibaldi

Related Features

Drug Delivery

Not Your Father’s Oral Thin Film

A look at how oral film drug delivery is evolving
Rodolphe Obeid, Vice President of Operations, IntelGenx 06.04.20
Functional Service Provision vs. Full-Service Outsourcing

Functional service provision and full-service outsourcing models have key roles to play in outsourced drug development as clinical trials evolve
Andrew MacGarvey, Managing Director, PHASTAR 06.04.20
Measuring the Success of Training as a CAPA

Implementing corrective and preventative actions through training
Will Kanyi, Senior Training Specialist, Catalent Biologics 06.04.20
Drug Delivery | Regulatory Affairs

European Regulatory Overhaul for Medical Devices

Implications for the pharmaceutical industry
Elizma Parry, Director, Global Clinical Practice, Maetrics 06.04.20
Supply Chain

Extended Content Labels

The simple yet complicated solution for pharma’s ever-expanding printed content needs
Tom Spina, President & CEO, Luminer 06.04.20
Biologics, Proteins, Vaccines

CAR-T Cell Therapy in Clinical Trials

The importance of CAR-T cell therapy in clinical trials: the industry’s evolving, maturing focus
Panteli Theocharous, Cell and Gene Therapy Strategy Lead, PPD 06.04.20
APIs | Cytotoxics and High Potency Manufacturing

The CDMO Landscape: Controlled Substance APIs

Meeting the growing demand for the development and manufacture of controlled substance APIs.
Mike Gibson, R&D Director, Sterling Pharma Solutions 06.04.20
Cytotoxics and High Potency Manufacturing

Highly Potent and Highly Specialized

CDMO model meets the HPAPI market demand.
Youchu Wang, VP Process R&D, WuXi STA 06.04.20
Biologics, Proteins, Vaccines

Cell Therapy Manufacturing

Addressing the growing pains in cell therapy manufacturing
Dr. Alessandra De Riva, Director of Process Development, Mogrify Ltd. 06.04.20
Supply Chain

Supply Chain Trends

Raising the performance of the pharmaceutical packaging supply chain
Rich Quelch, Global Head of Marketing, Origin 06.04.20
APIs | Facilities

Managing & Operating a Multipurpose API Plant

At multipurpose facilities CMOs have to manage various manufacturing demands.
Sandi Stolz-Dunn, Group Leader New Product Development, Cambrex Charles City 06.04.20
Biologics, Proteins, Vaccines

The New Wave of Innovation

Cell and gene therapies represent the new wave of innovation in the life sciences industry
Tim Wright, Editor, Contract Pharma 06.04.20
Supply Chain

Next-Gen Contract Packaging Trends

Insight into the latest pharma and biopharma trends, packaging innovations, challenges and opportunities
Kristin Brooks, Managing Editor, Contract Pharma 06.04.20
Hot Melt Coatings for Pharma Applications

GMP compliant hot melt device for applying pharmaceutical coatings
Kai Koch, R&D Director, Romaco Innojet 05.05.20
Solid Dosage/Creams/Ointments

Manufacturing of Solid Dosage Forms

Why outsourcing may represent the most viable pathway for innovators
Erik Haeffler, VP of Manufacturing Services and Head of Sustainability, Recipharm 05.05.20